Cotinga Pharmaceuticals Inc. (COTQF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.25 Million | -2.98 Million | -3.27 Million | -2.86 Million | -2504.38 | -1655.95 |
| Net Income | -2 Million | -3.8 Million | -4.54 Million | -3.93 Million | -3148.82 | -2732.09 |
| Depreciation & Amortization | 83.84 Thousand | 170.67 Thousand | 182.43 Thousand | 172.63 Thousand | 385.16 | 422.31 |
| Deferred income taxes | -122.48 Thousand | - | - | - | - | - |
| Stock-based compensation | 142.08 | 591.08 | 757.46 | 341.99 | 471.26 | 350.31 |
| Change in working capital | 390.84 Thousand | 996.15 Thousand | 840.3 Thousand | -118.27 Thousand | -39.94 | 17.48 |
| Other non-cash items | 395.01 Thousand | -18.4 Thousand | 617.41 Thousand | 1.34 Million | -172.04 | 286.04 |
| Investing Cash Flow | -9441.72 | 943.13 Thousand | 781.1 Thousand | -2.08 Million | -380.50 | -162.24 |
| Investments in PPE | -9553.23 | -65.34 Thousand | -163.74 Thousand | -225.89 Thousand | -13.66 | -3.61 |
| Acquisitions | 111.51 | 1294.12 | - | - | - | - |
| Investment purchases | - | - | - | -1.85 Million | - | - |
| Sales/Maturities of investments | - | 1 Million | 944.84 Thousand | - | - | - |
| Other Investing Activities | -9.48 | 943.49 | 796.25 | -2054.34 | -366.83 | -158.64 |
| Financing Cash Flow | 1.4 Million | 1.51 Million | 1.43 Million | 5.36 Million | 3470.72 | 2435.12 |
| Debt repayment | -148.65 Thousand | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 1.25 Million | 1.51 Million | 1.3 Million | 5.27 Million | - | - |
| Other Financing Activities | 1409.65 | 1629.04 | 128.22 Thousand | 92.93 Thousand | 3470.72 | 2435.12 |
| Accounts receivables | 45.35 Thousand | 13.91 Thousand | -11.45 Thousand | 11.38 Thousand | -30.89 | 11.27 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 345.48 Thousand | 982.24 Thousand | 851.76 Thousand | -129.65 Thousand | -9.04 | 6.21 |
| Cash at beginning of period | 31.77 Thousand | 524.88 Thousand | 1708.01 | 1320.59 | 757.09 | 168.14 |
| Cash at end of period | 166.97 Thousand | 31.77 Thousand | 524.88 Thousand | 1.71 Million | 1320.59 | 757.09 |
| Capital Expenditure | -9553.23 | -65.34 Thousand | -163.74 Thousand | -225.89 Thousand | -13.66 | -3.61 |
| Effect of forex changes on cash | -0.17 | - | 24.16 | 15.27 | 49.13 | -14.26 |
| Net cash flow / Change in cash | 135.2 Thousand | -493.11 Thousand | 523.17 Thousand | 1.7 Million | 563.49 | 588.95 |
| Free Cash Flow | -1.26 Million | -3.05 Million | -3.44 Million | -3.09 Million | -2518.04 | -1659.56 |
| Breakdown | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 FY | 2018 Q4 | 2018 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -403.21 | -407.46 | -399.13 | -2 Million | -702.58 | -212.97 |
| Depreciation & Amortization | 12.43 | 12.54 | 12.79 | 83.84 Thousand | 16.69 | 20.78 |
| Deferred income taxes | - | - | - | -122.48 Thousand | - | - |
| Stock-based compensation | - | - | 0.49 | 142.08 | -12.50 | 15.81 |
| Change in working capital | 19.42 | 25.62 | 28.17 | 390.84 Thousand | 6.79 | 15.92 |
| Other non-cash items | 316.61 | 277.79 | 180.64 | 395.01 Thousand | 624.83 | 173.39 |
| Investing Cash Flow | - | - | - | -9441.72 | - | -1.07 |
| Investments in PPE | - | - | - | -9553.23 | - | - |
| Acquisitions | - | - | - | 111.51 | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -9.48 | - | -1.07 |
| Financing Cash Flow | 64.22 | 83.51 | 40.29 | 1.4 Million | 149.26 | - |
| Debt repayment | - | - | - | -148.65 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 1.25 Million | - | - |
| Other Financing Activities | 64.22 | 83.51 | 40.29 | 1409.65 | 149.26 | - |
| Accounts receivables | - | - | - | 45.35 Thousand | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 19.42 | 25.62 | 28.17 | 345.48 Thousand | 6.79 | 15.92 |
| Cash at beginning of period | 25.49 | 33.42 | 167.66 | 31.77 Thousand | 86.84 | 74.83 |
| Cash at end of period | 34.84 | 25.49 | 33.42 | 166.97 Thousand | 167.66 | 86.84 |
| Capital Expenditure | - | - | - | -9553.23 | - | - |
| Effect of forex changes on cash | - | - | - | -0.17 | - | - |
| Net cash flow / Change in cash | 9.35 | -7.93 | -134.24 | 135.2 Thousand | 80.81 | 12.01 |
| Free Cash Flow | -54.75 | -91.51 | -177.04 | -1.26 Million | -66.78 | 12.93 |
RNC
600691
CNTB
AZM
GLENMARK
BPCR